{"id":"W4415069879","doi":"10.1016/j.jhepr.2025.101630","title":"Navigating second-line therapy after immunotherapy in advanced HCC☆","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Immunotherapy; Hepatocellular carcinoma; Clinical trial; Sorafenib; Disease; Systemic therapy; Tyrosine kinase; Therapeutic approach","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004197949,0.0002044419,0.0004026097,0.00008833343,0.00005287586,0.00002574023,0.00006168272,0.0001241939,0.001177849],"category_scores_gemma":[0.00002835445,0.0001717072,0.0001794275,0.0004661024,0.00006795688,0.0001094121,0.00002035817,0.0003455281,0.000004257286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001723588,"about_ca_system_score_gemma":0.0001844481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001258928,"about_ca_topic_score_gemma":0.00008610089,"domain_scores_codex":[0.9983848,0.00003246234,0.0007031172,0.0003935025,0.000192406,0.0002936957],"domain_scores_gemma":[0.99909,0.0000424506,0.0001852952,0.0005718304,0.00006696013,0.00004347114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007040279,0.000405974,0.1685964,0.0001023483,0.0002517151,0.00170643,0.0007768317,0.000005548826,0.1788785,0.00001091799,0.0005340038,0.6416911],"study_design_scores_gemma":[0.00761639,0.000475631,0.6597312,0.001435412,0.00001981948,0.0004988309,0.0002512614,0.00004145798,0.0817659,0.0005772848,0.2471784,0.0004084581],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774215,0.01504906,0.00004048253,0.001280526,0.0006750042,0.000636918,0.000002447764,0.00008245419,0.004811571],"genre_scores_gemma":[0.9900503,0.0009769469,0.0005275,0.004448673,0.00008287231,0.0001852154,0.00001918335,0.00002960511,0.003679724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6412826,"threshold_uncertainty_score":0.9997352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009116866115393253,"score_gpt":0.3164162341904891,"score_spread":0.3072993680750959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}